RSIP Vision
RSIP Vision is a privately held Israel-based software company that develops custom AI, deep learning, and computer vision algorithms for medical image analysis, embedding its technology as OEM components in medical devices across orthopedics, cardiology, gastroenterology, urology, and surgical specialties.
- Company typePrivate
- Founded2000
- HeadquartersJerusalem, Israel
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What RSIP Vision does
RSIP Vision is a privately held Israeli software company specializing in custom AI, deep learning, and computer vision solutions for medical image analysis. Founded in 1987 (with a 2000 incorporation date also cited in sources) and headquartered in Jerusalem, the company serves medical device manufacturers as its primary customer segment, embedding AI capabilities into OEM products across clinical specialties including orthopedics, cardiology, gastroenterology, urology, surgery, ENT, pulmonology, and ophthalmology. Its technology spans image segmentation, registration, tracking, 3D reconstruction, and real-time surgical navigation across CT, MRI, X-ray, ultrasound, endoscopy, and microscopy modalities, with disclosed benchmarks including sub-millimeter 2D-to-3D reconstruction accuracy validated in a peer-reviewed clinical study and 25-30 fps navigation update rates.
The company operates a platform-plus-modules architecture built around an RSIP Vision Core Platform and a portfolio of specialized modules (Bone Segmentation, Cartilage Assessment, Intraoperative Registration, Navigation Systems, IBD Scoring, Prostate Guidance, etc.), supplemented by two wholly-owned subsidiaries: XPlan.ai (2D-to-3D bone reconstruction from X-rays, with FDA clearance in pursuit) and RSIP Neph (AI-based intraoperative visual intelligence for urological procedures such as partial nephrectomy). The portfolio is supported by an in-house MLOps framework built on ClearML that handles versioning, experiment tracking, and model lineage for FDA-grade regulatory submissions. Named enterprise customers include Hologic, Activ Surgical, LinkBio, Biosense Webster (Johnson & Johnson), Clario, and GI Reviewers, with clinical research collaboration via Assuta Medical Center.
RSIP Vision generates revenue through project-based custom R&D development fees combined with OEM/embedded technology licensing arrangements, with pricing negotiated on a per-project basis and not publicly disclosed. Go-to-market is enterprise field sales led by CEO Ron Soferman and VP of Business Development Shmulik Shpiro, supported by presence at major medical conferences (AAOS, SAGES, AUA, NASS, DeviceTalks), a Computer Vision News magazine reaching 8,000+ professionals, and a technical blog. The firm has 51-100 employees, offices in Jerusalem, Tel Aviv, and San Jose, no disclosed external funding or valuation, and appears to be founder/management-owned.
RSIP Vision firmographics
Firmographics- Name
- RSIP Vision
- Legal name
- RSIP Vision
- Website
- https://rsipvision.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- RSIP Vision is a privately held Israel-based software company that develops custom AI, deep learning, and computer vision algorithms for medical image analysis, embedding its technology as OEM components in medical devices across orthopedics, cardiology, gastroenterology, urology, and surgical specialties.
- Ownership category
- akta.pro rank
RSIP Vision industry classification
Industry- Product category
- Medical Image Analysis Software
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
- akta.pro secondary industries
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing) (HLAHADAD)
Keywords
Where RSIP Vision is headquartered
LocationHeadquarters
- HQ city
- Jerusalem
- HQ country
- Israel
- HQ region
- Middle East
Offices3 records
Markets served
RSIP Vision business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Custom Software Development & Licensing: RSIP Vision develops custom computer vision and AI solutions for medical device companies, likely through project-based development fees and/or licensing arrangements. The company works through a transparent process from concept development through prototype, implementation, and productization, suggesting a combination of R&D services and embedded technology licensing.
- XPlan.ai Technology Licensing: The company's spinoff XPlan.ai provides AI-based 3D bone reconstructions from standard 2D X-rays for orthopedic applications. This technology is being developed for FDA clearance and represents a potential product licensing opportunity.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
RSIP Vision product offering
Product offeringCore offering
RSIP Vision develops custom computer vision and deep learning software for medical image analysis, providing algorithms and OEM-embedded AI capabilities to medical device manufacturers. The company delivers solutions across imaging modalities (CT, MRI, X-ray, ultrasound, endoscopy, microscopy) for segmentation, registration, tracking, 3D reconstruction, and intraoperative guidance, with end-to-end support from concept development through FDA regulatory productization.
Product overview
RSIP Vision is a world-class pioneer in medical image analysis and AI, offering field-tested software solutions and custom R&D prowess to power medical devices. The company operates a platform-plus-modules architecture with its core RSIP Vision platform providing AI capabilities across multiple medical specialties (cardiology, orthopedics, gastro, pulmonology, surgical, ENT, urology, ophthalmology). The portfolio includes specialized sub-brands XPlan.ai (2D-to-3D bone reconstruction from X-rays) and RSIP Neph (urology/partial nephrectomy solutions), plus various add-on modules for segmentation, registration, navigation, and procedure-specific guidance. The company focuses on custom R&D services, clinical validation, and FDA regulatory support rather than off-the-shelf products.
Differentiator
Problem solved
Functional benefit
Brands
- XPlan.ai: AI-based solution that provides 3D bone reconstructions from standard 2D X-rays for orthopedic surgery planning, including knee replacement procedures. Spinoff company of RSIP Vision.
- RSIP Neph
Products and services
- RSIP Vision Custom AI/Computer Vision Development for Medical Devices
Quantifiable outcome
- Sub-millimeter accuracy achieved in peer-reviewed clinical study for 2D-to-3D knee reconstruction using XPlan.ai technology
- +3 more outcomes
Companies that use RSIP Vision
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles2 records
RSIP Vision technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability18 records
Feature8 records
RSIP Vision partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- ClariocoreStrategic partnership for developing AI-based scoring system for Inflammatory Bowel Disease (IBD) clinical trials. Clario provides scientific leadership and clinical trials infrastructure; RSIP Vision provides AI technology. The solution automatically computes Mayo Endoscopic Score from colonoscopy videos, improving reproducibility and efficiency of clinical trial assessments.
- GI ReviewerscorePartnership providing clinical guidance and central reading expertise for IBD scoring AI development. GI Reviewers, led by Dr. Daniel Mishkin, contributes gastroenterology domain expertise and supervision for AI algorithm training using expert-scored colonoscopy videos.
- Assuta Medical CentercoreClinical research partnership for evaluating XPlan.ai technology. The study was conducted using imaging from total knee replacement patients at Assuta Medical Center in Tel-Aviv, a leading medical center in Israel. Dr. Shai Factor and Dr. Vadim Benkovich from Assuta participated in the peer-reviewed clinical study.
Scale indicators7 records
Recent moves7 records
Expansion highlights6 records
RSIP Vision competitors and assessment
Company assessmentBroad incumbents
- GE HealthCare: Major medical imaging OEM (CT, MRI, ultrasound, X-ray) integrating AI capabilities into devices. Comparable as a large incumbent with embedded imaging AI that competes for the same OEM and hospital relationships.
- Siemens Healthineers: Global medical imaging and diagnostics equipment OEM with embedded AI capabilities across CT, MRI, ultrasound. Comparable as a large incumbent offering AI-augmented imaging software as part of a broader medical device portfolio.
Direct peers
- Viz.ai: AI software for medical imaging, most notably for stroke detection and workflow coordination. Comparable as a clinical imaging AI company whose algorithms integrate into hospital and OEM imaging workflows.
- HeartFlow: AI-driven cardiovascular imaging analysis using CT scans to assess coronary artery disease. Comparable as a medical imaging AI company focused on a specific clinical specialty (cardiology) with regulatory-cleared product.
- Quibim: AI-powered medical imaging biomarker analysis for radiology and oncology. Comparable as a medical imaging AI software provider with multi-modality and multi-specialty coverage.
- Subtle Medical: AI for medical imaging enhancement (faster MRI, lower-dose PET). Comparable as an AI medical imaging software company focused on image acquisition and analysis quality.
- Arterys (Tempus): Cloud-native AI medical imaging platform with FDA-cleared products across multiple imaging modalities. Comparable as a medical imaging AI software company with regulatory-cleared offerings.
- icometrix: AI-based medical imaging analysis focused on brain MRI/CT. Comparable as a specialty-focused medical imaging AI software company with FDA-cleared products serving clinical workflows.
- Aidoc: AI-powered medical imaging platform providing clinical decision support across CT and other modalities. Directly comparable as a medical imaging AI software provider serving hospitals and integrated with imaging workflows.
- Paige.AI: AI for digital pathology and cancer detection in medical imaging. Comparable as an AI medical imaging company developing FDA-cleared diagnostic software for clinical use.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
RSIP Vision social profiles
Digital presenceRSIP Vision financial estimates
Financial estimateRevenue estimate
Valuation estimate
RSIP Vision leadership team
Management profileNumber of profiles
Profiles8 records
RSIP Vision subsidiaries and ownership
Company hierarchySubsidiaries2 records
RSIP Vision funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RSIP Vision M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RSIP Vision
What does RSIP Vision do?
RSIP Vision develops custom computer vision and deep learning software for medical image analysis, providing algorithms and OEM-embedded AI capabilities to medical device manufacturers. The company delivers solutions across imaging modalities (CT, MRI, X-ray, ultrasound, endoscopy, microscopy) for segmentation, registration, tracking, 3D reconstruction, and intraoperative guidance, with end-to-end support from concept development through FDA regulatory productization.
Is RSIP Vision a public or private company?
RSIP Vision is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was RSIP Vision founded?
RSIP Vision was founded in 2000. It employs 51 to 100 people.
Where is RSIP Vision based?
RSIP Vision is headquartered in Jerusalem, Israel, in the Middle East region.
How does RSIP Vision make money?
Two revenue lines are on record. Custom Software Development & Licensing is the primary driver. The others are XPlan.ai Technology Licensing.
Who are RSIP Vision's main competitors?
Broad incumbents on record are GE HealthCare and Siemens Healthineers. Direct peers are Viz.ai, HeartFlow, Quibim, Subtle Medical, Arterys (Tempus), icometrix, Aidoc and Paige.AI.
Does RSIP Vision have an API?
No public API is recorded for RSIP Vision.
What industry is RSIP Vision in?
RSIP Vision's product category is Medical Image Analysis Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software. Its SIC code is 3841.